Expertise in
2
conditions

Renaud Verdon

CHU Caen
Caen, FR 
Expertise in
2
conditions
CHU Caen
Caen, FR 

Overview

Renaud Verdon practices practicing medicine in Caen, France.

Mr. Verdon is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pelvic Inflammatory Disease, Endocarditis, Secondary Peritonitis, Bone Marrow Aspiration, and Splenectomy.

He is actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

CHU Caen
Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drugs: Levofloxacin, Rifampicin
Study Phase: Phase 3
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drug: Amoxicillin
Study Phase: Phase 3
Randomized Clinical Trial to Evaluate the Interest of a Down-scaled Treatment Strategy Using Dual Therapy (Nucleoside Analogs) in HIV Infected Patients Already Being Treated Using Triple Therapy, Who Present With a Successful Virological Control and for Which the HIV Reservoir is Low to Moderate
Randomized Clinical Trial to Evaluate the Interest of a Down-scaled Treatment Strategy Using Dual Therapy (Nucleoside Analogs) in HIV Infected Patients Already Being Treated Using Triple Therapy, Who Present With a Successful Virological Control and for Which the HIV Reservoir is Low to Moderate
Enrollment Status: Completed
Publish Date: December 26, 2025
Intervention Type: Drug
Study Phase: Phase 3
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin in the Treatment of Staphylococcal Bone and Joint Infections
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin in the Treatment of Staphylococcal Bone and Joint Infections
Enrollment Status: Completed
Publish Date: August 23, 2021
Intervention Type: Drug
Study Phase: Phase 4
Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial
Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: July 01, 2021
Intervention Type: Drug
Study Drugs: Tenofovir, Emtricitabine
Study Phase: Phase 2/Phase 3
Dosing of Antibiotics (Serum and Periprosthetic Tissues) During Reimplantation of Infected Knee and Hip Prostheses
Dosing of Antibiotics (Serum and Periprosthetic Tissues) During Reimplantation of Infected Knee and Hip Prostheses
Enrollment Status: Completed
Publish Date: October 11, 2017
View 5 Less Clinical Trials

79 Total Publications

Phenotypic and genotypic characterization of clinical Staphylococcus lugdunensis isolates: a French retrospective cohort study.
Phenotypic and genotypic characterization of clinical Staphylococcus lugdunensis isolates: a French retrospective cohort study.
Journal: Microbiology spectrum
Published: June 24, 2026

Frequently Asked Questions about Renaud Verdon

Is Renaud Verdon a top-rated expert for Pelvic Inflammatory Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Renaud Verdon is classified as an Advanced expert for Pelvic Inflammatory Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Renaud Verdon participate in research or clinical trials?

Yes. Renaud Verdon has published 79 articles and abstracts on conditions like Pelvic Inflammatory Disease. You can view a list of Renaud Verdon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Verdon's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile